[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368430-105":59,"doc-detail-368430-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","network-based-integrative-analysis-to-identify-key-genes-and-corresponding-reporter-biomolecules-for-triple-negative-breast-cancer","Network-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer","","Triple-negative breast cancer (TNBC) drives high mortality in Indian women and represents a major global burden, defined by the absence of ER, PR, and HER2 receptor expression. Limited treatment options stem from the lack of specific therapeutic targets. This integrative network study combines PPI and WGCNA analyses of TNBC datasets (GSE52194, GSE58135) to nominate key genes and downstream regulatory reporter biomolecules.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/network-based-integrative-analysis-to-identify-key-genes-and-corresponding-reporter-biomolecules-for-triple-negative-breast-cancer/368430/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/network-based-integrative-analysis-to-identify-key-genes-and-corresponding-reporter-biomolecules-for-triple-negative-breast-cancer/368430.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is TNBC considered difficult to treat?","Question",{"text":112,"@type":113},"TNBC lacks expression of key receptors ER, PR, and HER2, so standard receptor-targeted therapies are ineffective. This absence leaves few specific actionable targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which analytical strategies are used in the study?",{"text":117,"@type":113},"The study integrates PPI and WGCNA analyses using TNBC datasets GSE52194 and GSE58135. It then performs downstream analyses to explore potential therapeutic targets.",{"name":119,"@type":110,"acceptedAnswer":120},"What main biomarkers does the analysis identify?",{"text":121,"@type":113},"The analysis highlights 13 key genes and their associated transcription factors (6 TFs) and microRNAs (20 miRNAs). Enrichment and cumulative survival analyses support links between these key genes and TNBC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368430,1790827286,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nNetwork-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer  \nPooja Singh1 | Rupesh Chaturvedi2  | Pallavi Somvanshi1   \n1School of Computational & Sciences (SCIS), Jawaharlal Nehru University, New Delhi, India | 2School of Biotechnology (SBT), Jawaharlal Nehru University, New Delhi, India  \nCorrespondence: Pallavi Somvanshi ([psomvanshi@jnu.ac.in](psomvanshi@jnu.ac.in); [psomvanshi@gmail.com](psomvanshi@gmail.com))  \nReceived: 23 September 2024 | Revised: 23 January 2025 | Accepted: 29 January 2025  \nFunding: The authors received no specific funding for this work.  \nKeywords: cumulative survival analysis | key gene | reporter biomolecule | triple negative breast cancer  \nABSTRACT  \nBackground: The malignant neoplasm of the TNBC is the leading cause of death among Indian women. Recent studies identified the global burden ofTNBC affecting approximately more than 40 percent of all BC cases in women worldwide. The absence of expression of receptors such as ER, PR, and HER2 characterizes TNBC.  \nObjectives: Due to the lack of specific targets, standard treatment options for TNBC are limited. This integrative study aims to identify key genes and provide insights into the underlying molecular mechanisms of TNBC, which can potentially lead to the development of more effective therapeutic strategies.  \nMaterial and Methodology: This study integrates PPI and WGCNA analysis of TNBC-related datasets (GSE52194 and GSE58135) to identify key genes. Subsequently, downstream analysis is conducted to explore potential therapeutic targets for TNBC.  \nResults: The present study renders the potential 13 key genes (PLCG2, CXCL10, CDK1, STAT1, IL6, PLK1, CCNB1, AURKA, NDC80, EGFR, 1L1B, FN1, BUB1B), along with their associated 6 TFs and 20 miRNAs, as reporter biomolecules around which the most significant changes occur. There were some miRNAs hsa-mir-449b-5p, hsa-let-7b-5p, hsa-mir-26a-5p, hsa-mir-155-5p, hsa-mir-24-3p, hsa-mir-212-3p, hsa-mir-21-5p, hsa-mir-210-3p and hsa-mir-20a-5p whose association with other cancers and other BC subtypes have been reported but their association with TNBC need to be explored. Further, enrichment and cumulative survival analysis support the disease association of identified key genes with TNBC.  \nConclusion: This integrative analysis could be regarded for experimental inspection as it provides the platform for future researchers in drug designing and biomarker discovery for TNBC diagnosis and treatment.  \n1 | Introduction  \nBreast cancer (BC) accounting for 12% of all prevailing cancers worldwide is a serious concern for public health globally [1] . Due to its heterogenous nature, BC is categorized into three main groups based on cellular receptor markers reflecting available  \ntargeted therapies: (a) estrogen receptor (ER) or progesterone receptor (PR) positive; (b) human epidermal growth factor receptor 2 (HER2) positive (amplification of erbB2) with or without ER and PR positivity; and (c) triple-negative breast cancer (TNBC) defined by the absence of all kinds of receptor markers expression like ER, PR, and HER2 [2] . Due to the advancement  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2025; 14:e70674 1 of 16  \n[https://doi.org/10.1002/cam4.70674](https://doi.org/10.1002/cam4.70674)  \nof genomics technologies and proper management by government authorities, major contributing factors responsible for TNBC surveillance and prevention have been identified. Still, there are no standard treatment options available for TNBC because it does not respond to drugs that target receptors like ER, PR, and HER2, which accounts for 10%–20% of all invasive ","cbCaikqbf5NAKz7p","https://ap.wps.com/l/cbCaikqbf5NAKz7p","pdf",5878297,16,"English","# Abstract\n# Introduction\n# Material and Methodology\n# Results\n# Conclusion","[{\"question\":\"Why is TNBC considered difficult to treat?\",\"answer\":\"TNBC lacks expression of key receptors ER, PR, and HER2, so standard receptor-targeted therapies are ineffective. This absence leaves few specific actionable targets.\"},{\"question\":\"Which analytical strategies are used in the study?\",\"answer\":\"The study integrates PPI and WGCNA analyses using TNBC datasets GSE52194 and GSE58135. It then performs downstream analyses to explore potential therapeutic targets.\"},{\"question\":\"What main biomarkers does the analysis identify?\",\"answer\":\"The analysis highlights 13 key genes and their associated transcription factors (6 TFs) and microRNAs (20 miRNAs). Enrichment and cumulative survival analyses support links between these key genes and TNBC.\"}]","Network-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer | PDF",1790176922,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eab3df4824a659ff8aa5f73a6e4ae5aa.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c870a9304a367e06eb397489ce29385.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8938ad42f068d89dd2df56f3e544dd3.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ceaec587b3ca4780d3794c152c9a1c7b.webp",980,1287]